New drug tested to stop dangerous bleeding fast
NCT ID NCT03288454
Summary
This study tested a new drug called ciraparantag to see if it could quickly reverse the effects of a common blood thinner (apixaban). The goal was to help control dangerous bleeding in emergencies. Healthy volunteers took the blood thinner and then received either the reversal drug or a placebo to measure how well and how fast their blood returned to normal clotting.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Frontage Clinical Services Inc.
Secaucus, New Jersey, 07094, United States
Conditions
Explore the condition pages connected to this study.